Repligen | RGEN - Devedores Comerciais

Preço das Ações
117.61
Mudança Diária
0.02 0.02%
Mensal
-13.32%
Anual
-15.59%
Q1 Previsão
110.75




Devedores Comerciais Alterar Data
Agilent USD 1.52B 34M 2025-12
Align Technology USD 1.1B 2.38M 2025-12
Bio Techne USD 184.61M 717K 2025-12
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Bruker USD 544.9M 6M 2025-12
Charles River Laboratories USD 1.43B 54.59M 2025-12
Danaher USD 3.91B 762M 2025-12
Dentsply International USD 688M 34M 2025-12
Exact Sciences USD 306.05M 47.28M 2025-09
General Electric Aerospace USD 15.28B 1.5B 2025-12
Henry Schein USD 1.65B 92M 2025-12
Illumina USD 854M 125M 2025-12
IQVIA Holdings USD 3.43B 113M 2025-12
Mettler Toledo International USD 778.24M 90.98M 2025-12
Myriad Genetics USD 115.3M 2.7M 2025-12
OraSure Technologies USD 22.2M 2.1M 2025-12
Pacific Biosciences Of California USD 35.45M 4.83M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Repligen USD 158.59M 9.62M 2025-12
Revvity USD 744.67M 64.41M 2025-12
Standard Biotools USD 13.43M 109K 2025-12
Thermo Fisher Scientific USD 8.9B 11M 2025-12
Waters USD 828.84M 80.32M 2025-12
West Pharmaceutical Services USD 574.4M 50.6M 2025-12